Poland· PL-100179906

Dicloabak

A diclofenac product containing diclofenacum natricum, registered in Poland by Laboratoires Thea. The same ATC class is registered in 13 of our 19 countries.

ATC S01BC03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDicloabakATCS01BC03REGISTER NO.PL-100179906PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Diclofenac is registered in 13 of 19 countries.

Countries holding a registration under ATC S01BC03 (diclofenac), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Diclofenac · ATC S01BC03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Diclofenacum natricum
Manufacturer
Laboratoires Thea
Country
Poland (PL)
ATC code
S01BC03
ATC class
Diclofenac
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • gtin
    05909990074044
    10 ml
    PLN 21.49

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

90 interactions on record for diclofenac.

Graded by severity as the source publishes them — 89 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Diclofenac · interactions on record

90 records

  • 89 moderate
  • 1 minor

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • HeparinB01AB01moderate
  • Antithrombin IIIB01AB02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Diclofenac in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diclofenac products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Dedolor Akut, Dedolor Drs
  • Belgium · Cataflam, Dicloabak
  • Bulgaria · Diclofenac-Tchaikapharma, Алмирал
  • Cyprus · Almiral, Areston
  • Czechia · Almiral, Dicloabak
  • Germany · Arthrex Schmerzgel, Diclac
  • Denmark · Diclodan, Diclofenac Bluefish
  • Estonia · Almiral, Dagesil
  • Spain · Cinfadol, Dagesil
  • Finland · Dicloabak, Diclomex Rapid
  • France · Antalcalm, Diclamine
  • United Kingdom (Northern Ireland) · Akis, Amgesic Muscle & Back Pain Relief
  • Greece · Batafil, Denaclof
  • Croatia · Diclac Duo, Diclo Duo
  • Hungary · Algoplast, Cataflam
  • Ireland · Cataflam, Diclac
  • Iceland · Diclofenac Alvogen, Dimax
  • Italy · Brexiadvance, Dealgic
  • Lithuania · Dagesil, Diclac
  • Luxembourg · Cataflam, Dicloabak
  • Latvia · Almiral, Dagesil
  • Malta · Almiral, Areston
  • Netherlands · Areston, Dicloabak
  • Norway · Cataflam, Diclofenac Bluefish
  • Portugal · Dagesil, Dicipan
  • Romania · Almiral, Clafen
  • Sweden · Dicloabak, Diclofenac Bluefish
  • Slovenia · Diclo Duo, Dicloflex
  • Slovakia · Akis Plus, Almiral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/09f60bf4-bb3b-4da1-8c20-dd742e691116
GET /v1/drugs/09f60bf4-bb3b-4da1-8c20-dd742e691116?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "1 mg/ml",
  "packaging": "05909990074044 ¦ Rp ¦ 62169\n1 butelka 10 ml",
  "substance": "Diclofenacum natricum 10,00 mg/ 10 ml (1 mg/ml)",
  "common_name": "Diclofenacum natricum",
  "pl_product_id": "100179906",
  "pozwolenie_nr": "14116",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

See everything about diclofenac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.